A rapid and reliable strategy for identification of LNP and protein corona in vitro and in vivo

This study develops an integrated analytical method for visual verification and subsequent analysis of lipids and protein coronas of lipid nanoparticles (LNPs) in vitro and in vivo. In this strategy, SDS-PAGE combined with Coomassie brilliant blue (CBB) staining enabled rapid and reliable visual verification and semi-quantification of LNPs/lipids in solutions, yielding a linear standard curve of R 2 = 0.992. LC-MS/MS and GC–MS provided specific detection and quantification of key lipids (SM-102, DSPC, DMG-PEG2000, cholesterol), with excellent linearity for all four lipids (R 2 > 0.90). DMG-PEG2000 was quantifiable in the original LNP formulation but could not be reliably quantified after gel extraction due to the sample processing workflow. LNPs and associated protein corona were separated by SDS-PAGE and visualized by CBB after isolation from bulk solutions by size-exclusion chromatography (SEC) or sucrose density gradient centrifugation (S-DGC). LC-MS/MS and GC–MS detected SM-102, DSPC and cholesterol respectively in the forefront of SDS-PAGE gel loaded with factions eluted in the first peak of SEC chromatogram or the pellet layer of S-DGC. TEM confirmed the presence of intact LNPs in these fractions. We found that samples collected from both SEC and S-DGC yielded highly consistent protein coronas as measured by protein MS, enriched in apolipoproteins, immune-related proteins. In addition, pathways such as complement/coagulation and cholesterol metabolism were enriched. Importantly, SEC/SDS-PAGE/CBB combined with protein MS were successfully used to analyze in vivo LNP/protein corona, which revealed stark differences in composition between in vivo and in vitro protein corona, with opsonins such as immunoglobulins enriched in the former. Furthermore, we demonstrated that SDS-PAGE/CBB could be effectively used to indirectly assess LNP uptake by cells. In summary, a rapid and reliable analytical metheod for simultaneous detection of LNP and protein corona with visual verification is validated, which will improve quality control in study of LNP protein corona.

Authors

Institutions

Publication Details

Journal
International Journal of Pharmaceutics X
Published
2026-03-17
DOI
https://doi.org/10.1016/j.ijpx.2026.100519
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A rapid and reliable strategy for identification of LNP and protein corona in vitro and in vivo

Guanghui Zi, Ting Li, Hui Wang, Rui Wang et al.
International Journal of Pharmaceutics X
Nanoparticle-Based Drug Delivery
article

A rapid and reliable strategy for identification of LNP and protein corona in vitro and in vivo

Guanghui Zi, Ting Li, Hui Wang, Rui Wang, Baowei Peng, Zhenyu Yang, Yuhong Xu
article en

Abstract

This study develops an integrated analytical method for visual verification and subsequent analysis of lipids and protein coronas of lipid nanoparticles (LNPs) in vitro and in vivo. In this strategy, SDS-PAGE combined with Coomassie brilliant blue (CBB) staining enabled rapid and reliable visual verification and semi-quantification of LNPs/lipids in solutions, yielding a linear standard curve of R 2 = 0.992. LC-MS/MS and GC–MS provided specific detection and quantification of key lipids (SM-102, DSPC, DMG-PEG2000, cholesterol), with excellent linearity for all four lipids (R 2 > 0.90). DMG-PEG2000 was quantifiable in the original LNP formulation but could not be reliably quantified after gel extraction due to the sample processing workflow. LNPs and associated protein corona were separated by SDS-PAGE and visualized by CBB after isolation from bulk solutions by size-exclusion chromatography (SEC) or sucrose density gradient centrifugation (S-DGC). LC-MS/MS and GC–MS detected SM-102, DSPC and cholesterol respectively in the forefront of SDS-PAGE gel loaded with factions eluted in the first peak of SEC chromatogram or the pellet layer of S-DGC. TEM confirmed the presence of intact LNPs in these fractions. We found that samples collected from both SEC and S-DGC yielded highly consistent protein coronas as measured by protein MS, enriched in apolipoproteins, immune-related proteins. In addition, pathways such as complement/coagulation and cholesterol metabolism were enriched. Importantly, SEC/SDS-PAGE/CBB combined with protein MS were successfully used to analyze in vivo LNP/protein corona, which revealed stark differences in composition between in vivo and in vitro protein corona, with opsonins such as immunoglobulins enriched in the former. Furthermore, we demonstrated that SDS-PAGE/CBB could be effectively used to indirectly assess LNP uptake by cells. In summary, a rapid and reliable analytical metheod for simultaneous detection of LNP and protein corona with visual verification is validated, which will improve quality control in study of LNP protein corona.

International Journal of Pharmaceutics XVol. 11
Dali University (CN)
Openalex Percentile: Top 23%
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.